On the public citation graph

Investigation of the effect of molecular properties on the binding kinetics of a ligand to its biological target

0 signed · 68 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s10822-011-9442-0openalex-snapshot
Application of shape-based and pharmacophore-based in silico screens for identification of Type II protein kinase inhibitors
inferredcites →https://doi.org/10.1016/j.ab.2008.11.021openalex-snapshot
A global benchmark study using affinity-based biosensors
inferredcites →https://doi.org/10.1016/j.tips.2006.05.001openalex-snapshot
Slow antagonist dissociation and long-lasting in vivo receptor protection
inferredcites →https://doi.org/10.1016/s0026-895x(25)15016-5openalex-snapshot
The kinetics of competitive radioligand binding predicted by the law of mass action.
inferredcites →https://doi.org/10.1021/ci100340wopenalex-snapshot
Sequence, Structure, and Active Site Analyses of p38 MAP Kinase: Exploiting DFG-out Conformation as a Strategy to Design New Type II Leads
inferredcites →https://doi.org/10.1021/jm8010299openalex-snapshot
Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States
inferredcites →https://doi.org/10.1038/nrd1500openalex-snapshot
Biochemical mechanisms of drug action: what does it take for success?
inferredcites →https://doi.org/10.1038/nrd2082openalex-snapshot
Drug–target residence time and its implications for lead optimization
inferredcites →https://doi.org/10.1038/nsb770openalex-snapshot
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
inferredcites →https://doi.org/10.1111/j.1476-5381.2010.00936.xopenalex-snapshot
Long‐lasting target binding and rebinding as mechanisms to prolongin vivodrug action
inferredcites →https://doi.org/10.1517/17460440802580106openalex-snapshot
Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition
inferredcites →https://doi.org/10.2174/092986710791859333openalex-snapshot
Non-ATP Competitive Protein Kinase Inhibitors
inferredcites →https://doi.org/10.2174/156802606776743093openalex-snapshot
Biochemical Mechanisms of New Molecular Entities (NMEs) Approved by United States FDA During 2001-2004: Mechanisms Leading to Optimal Efficacy and Safety
inferredcites →https://doi.org/10.2174/157018006778194754openalex-snapshot
Can Binding Kinetics Translate to a Clinically Differentiated Drug? From Theory to Practice

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9783527673025.ch10openalex-snapshot
Challenges in the Medicinal Chemical Optimization of Binding Kinetics
inferred← citeshttps://doi.org/10.1002/9783527673025.ch12openalex-snapshot
The Use of Structural Information to Understand Binding Kinetics
inferred← citeshttps://doi.org/10.1002/chem.201802599openalex-snapshot
KinITC—One Method Supports both Thermodynamic and Kinetic SARs as Exemplified on FimH Antagonists
inferred← citeshttps://doi.org/10.1002/cmdc.201402521openalex-snapshot
The Use of Thermodynamic and Kinetic Data in Drug Discovery: Decisive Insight or Increasing the Puzzlement?
inferred← citeshttps://doi.org/10.1002/cmdc.201500310openalex-snapshot
The Role of Target Binding Kinetics in Drug Discovery
inferred← citeshttps://doi.org/10.1002/med.21307openalex-snapshot
Drug‐Target Residence Time—A Case for G Protein‐Coupled Receptors
inferred← citeshttps://doi.org/10.1007/978-1-0716-1787-8_8openalex-snapshot
Predicting Residence Time of GPCR Ligands with Machine Learning
inferred← citeshttps://doi.org/10.1007/978-1-0716-3461-5_1openalex-snapshot
Molecular Modeling Techniques and In-Silico Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-3-319-35072-1_12openalex-snapshot
Beyond Membrane Protein Structure: Drug Discovery, Dynamics and Difficulties
inferred← citeshttps://doi.org/10.1007/978-94-007-7423-0_7openalex-snapshot
From Three-Dimensional GPCR Structure to Rational Ligand Discovery
inferred← citeshttps://doi.org/10.1007/s00232-026-00385-4openalex-snapshot
Impact of Time, Temperature, and Conformational Changes on the Characterization of Cardiotonic Steroid–Na+/K+-ATPase Interactions
inferred← citeshttps://doi.org/10.1007/s11030-026-11686-0openalex-snapshot
Scoring pesticide-likeness of organic compounds via explainable one-class machine learning
inferred← citeshttps://doi.org/10.1016/b978-0-12-407865-9.00015-7openalex-snapshot
From Heptahelical Bundle to Hits from the Haystack
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00011-6openalex-snapshot
Kinetics of Drug-Target Binding: A Guide for Drug Discovery
inferred← citeshttps://doi.org/10.1016/j.bcp.2018.03.018openalex-snapshot
Structure-kinetic relationship studies of cannabinoid CB 2 receptor agonists reveal substituent-specific lipophilic effects on residence time
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.08.028openalex-snapshot
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: The role of a hydrogen-bond acceptor in long receptor residence times
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.02.027openalex-snapshot
Design strategies to address kinetics of drug binding and residence time
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.03.084openalex-snapshot
Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective
inferred← citeshttps://doi.org/10.1016/j.cbpa.2018.06.002openalex-snapshot
Structure–kinetic relationships that control the residence time of drug–target complexes: insights from molecular structure and dynamics
inferred← citeshttps://doi.org/10.1016/j.csbj.2020.12.030openalex-snapshot
Intense bitterness of molecules: Machine learning for expediting drug discovery
inferred← citeshttps://doi.org/10.1016/j.ddtec.2015.08.003openalex-snapshot
On-rate based optimization of structure–kinetic relationship – surfing the kinetic map
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.02.007openalex-snapshot
Molecular determinants of drug–receptor binding kinetics
inferred← citeshttps://doi.org/10.1016/j.drudis.2017.02.002openalex-snapshot
Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
inferred← citeshttps://doi.org/10.1016/j.mce.2019.01.018openalex-snapshot
Binding kinetics of ligands acting at GPCRs
inferred← citeshttps://doi.org/10.1016/j.tips.2020.10.003openalex-snapshot
Fluxes for Unraveling Complex Binding Mechanisms
inferred← citeshttps://doi.org/10.1021/acs.biochem.6b01112openalex-snapshot
Mechanism of the Association Pathways for a Pair of Fast and Slow Binding Ligands of HIV-1 Protease
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00450openalex-snapshot
Baseline Model for Predicting Protein–Ligand Unbinding Kinetics through Machine Learning
inferred← citeshttps://doi.org/10.1021/acs.jcim.5b00632openalex-snapshot
Toward High-Throughput Predictive Modeling of Protein Binding/Unbinding Kinetics
inferred← citeshttps://doi.org/10.1021/acs.jctc.9b00069openalex-snapshot
Fragment Binding Pose Predictions Using Unbiased Simulations and Markov-State Models
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00974openalex-snapshot
Structure–Kinetic Relationship Studies for the Development of Long Residence Time LpxC Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00576openalex-snapshot
Are We There Yet? Applying Thermodynamic and Kinetic Profiling on Embryonic Ectoderm Development (EED) Hit-to-Lead Program
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00447openalex-snapshot
Route to Prolonged Residence Time at the Histamine H1 Receptor: Growing from Desloratadine to Rupatadine
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00716openalex-snapshot
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles
inferred← citeshttps://doi.org/10.1021/acschembio.0c00911openalex-snapshot
Warhead Reactivity Limits the Speed of Inhibition of the Cysteine Protease Rhodesain
inferred← citeshttps://doi.org/10.1021/acschembio.6b00979openalex-snapshot
Elucidating the Origin of Long Residence Time Binding for Inhibitors of the Metalloprotease Thermolysin
inferred← citeshttps://doi.org/10.1021/acsomega.0c06358openalex-snapshot
Exploring the Effect of Cyclization of Histamine H1 Receptor Antagonists on Ligand Binding Kinetics
inferred← citeshttps://doi.org/10.1021/cb500870aopenalex-snapshot
Targeting Conformational Plasticity of Protein Kinases
inferred← citeshttps://doi.org/10.1021/jacs.8b08048openalex-snapshot
Binding Kinetics Survey of the Drugged Kinome
inferred← citeshttps://doi.org/10.1021/jm401643mopenalex-snapshot
Agonists for the Adenosine A1Receptor with Tunable Residence Time. A Case for Nonribose 4-Amino-6-aryl-5-cyano-2-thiopyrimidines
inferred← citeshttps://doi.org/10.1039/c6md00269bopenalex-snapshot
Differentiating between drugs with short and long residence times
inferred← citeshttps://doi.org/10.1080/07391102.2024.2426078openalex-snapshot
Binding kinetics of highly mutated HIV-1 subtype C protease inhibition by Lopinavir and Darunavir in the face of altered conformational dynamics
inferred← citeshttps://doi.org/10.1080/17460441.2026.2619070openalex-snapshot
Understanding drug-target residence time and the implications on drug discovery
inferred← citeshttps://doi.org/10.1111/1750-3841.16904openalex-snapshot
Potential molecular mechanism of reuterin on the inhibition of Aspergillus flavus conidial germination: An in silico study
inferred← citeshttps://doi.org/10.1111/bph.12248openalex-snapshot
A structural chemogenomics analysis of aminergic GPCRs : lessons for histamine receptor ligand design
inferred← citeshttps://doi.org/10.1111/bph.12967openalex-snapshot
Kv11.1 ( hERG )‐induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv11.1 ( hERG ) inhibitors
inferred← citeshttps://doi.org/10.1111/cbdd.13949openalex-snapshot
SAR study of small molecule inhibitors of the programmed cell death‐1/programmed cell death‐ligand 1 interaction
inferred← citeshttps://doi.org/10.1128/jvi.01533-19openalex-snapshot
Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope
inferred← citeshttps://doi.org/10.1134/s199075082003004xopenalex-snapshot
Ligand–Receptor Binding Kinetics in Drug Design
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-22-0721openalex-snapshot
Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1517/17460441.2012.715631openalex-snapshot
Ligand–receptor interaction platforms and their applications for drug discovery
inferred← citeshttps://doi.org/10.18097/pbmc20206601042openalex-snapshot
Ligand-receptor binding kinetics in drug design
inferred← citeshttps://doi.org/10.3410/f.736768409.793566916openalex-snapshot
Faculty Opinions recommendation of Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope.
inferred← citeshttps://doi.org/10.4155/fmc.14.7openalex-snapshot
Potential Strategies for Increasing Drug-Discovery Productivity
inferred← citeshttps://doi.org/10.70675/1d581f29z4cb3z4657z941ezb57faa759067openalex-snapshot
Prédiction des constantes cinétiques de complexes protéine-ligand
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.